Navigation Links
Karo Bio Announces Sucessfule Phase II Results of KB2115

HUDDINGE, Sweden,11-Jun-2007 / Karo Bio (STO:KARO) successful KB2115 Phase II study meets primary objectives. The 12 week proof of concept phase II study with KB2115 in patients with dyslipidemia has been successfully completed. KB2115 is efficacious in LDL lowering and safe with respect to a broad range of parameters reflecting effects on heart, bone, muscle and thyroid function.

The thyroid hormone receptor (TR) is a key regulator of metabolic pathways and holds the promise of a new target for the treatment of dyslipidemia. KB2115 is an innovative and first in class liver selective agonist for the TR. Unlike the natural thyroid hormones, KB2115 is a liver selective TR agonist that can induce pharmacological effects in the liver, while a normal thyroid state is preserved in the rest of the body.

The completed 12 week, placebo controlled, double blind, randomised, clinical phase II study in 99 patients with high cholesterol levels was designed to explore whether a clinically relevant LDL-cholesterol lowering effect can be achieved without affecting the heart, bone, muscle and thyroid function.

The study demonstrated that a pronounced and clinically relevant lowering of LDL cholesterol can be obtained while preserving the thyroid homeostasis outside the liver and biomarkers for heart, bone, muscle and other organs were kept at normal levels. The mild increase in liver enzymes that was picked up in the previous 2-week phase I trial, was observed in this study as well, however, it seems to be a transient and benign effect. In addition to the positive result regarding efficacy and safety it was also shown that the enteric coating of KB2115 was effective in protecting the compound from chemical modification in the stomach.Thereby, a safety concern for longer exposure in man is removed.

The specific results from the KB2115 phase II study will be presented at upcoming international conferences dur
'"/>




Page: 1 2 3

Related medicine technology :

1. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
2. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
3. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
4. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
5. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. Protox Announces Positive Clinical Data from Prostate Cancer Study
10. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
11. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Karo Bio Announces Sucessfule Phase Results
(Date:12/14/2009)... -- In response to an FDA notice ... the Agency recommended that healthcare facilities discontinue use ... system, hospitals throughout the U.S. are faced with ... product. According to the FDA, STERIS made changes ... affect the safety or the effectiveness of the ...
(Date:12/14/2009)... Following is a statement by Linda ... Products Association (CHPA), regarding today,s release of the ... Future survey: ,, "Findings released today on this ... need for continued efforts to educate and empower ... to their teens about medicine abuse. The Consumer ...
(Date:12/14/2009)... -- The board of directors of Eli Lilly and ... dividend for the first quarter of 2010 of $0.49 ... The dividend is payable March 10, 2010 to shareholders ... ,, February 12, 2010. ,, Lilly, a leading innovation-driven ... by applying the latest research from its own worldwide ...
Breaking Medicine Technology:ECRI Institute Issues Steris System 1 High Priority Alert and Recommendations: Free Guidance to Help Hospitals Map out Transition to Alternative Reprocessing Methods 2ECRI Institute Issues Steris System 1 High Priority Alert and Recommendations: Free Guidance to Help Hospitals Map out Transition to Alternative Reprocessing Methods 3Statement From the Consumer Healthcare Products Association(CHPA) on Annual Monitoring the Future Survey on Drug Abuse 2Statement From the Consumer Healthcare Products Association(CHPA) on Annual Monitoring the Future Survey on Drug Abuse 3Advancement Made in Automatic Autism Screen Increases Accuracy to 91 25 Scheduled for Release This Month 13802 1Advancement Made in Automatic Autism Screen Increases Accuracy to 91 25 Scheduled for Release This Month 13802 2Advancement Made in Automatic Autism Screen Increases Accuracy to 91 25 Scheduled for Release This Month 13802 3The Next 100 Days 3A Some Final Hurdles to Health Reform 56011 1The Next 100 Days 3A Some Final Hurdles to Health Reform 56011 2Hospital infections cost 241 billion in lost bed days 56007 1Hospital infections cost 241 billion in lost bed days 56007 2
... International Corporation (Nasdaq: PRXL ), a ... it has opened an office in Lima, Peru ... With the addition of the Peru office, PAREXEL ... in Latin America, which also include Argentina, Brazil, ...
... critical enzyme,s regulation may hold key to understanding how to better ... MEMPHIS, Tenn., Nov. 19 Scientists at St. Jude ... of the body,s enzyme workhorses called calpains. , ... in many cellular processes, including the movement of cells in tissues, ...
Other Medicine Technology:PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 2PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 3PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 4New Insight Into the Controls on a Go-To Enzyme 2New Insight Into the Controls on a Go-To Enzyme 3
(Date:12/14/2009)... Attitudes and Behavior Regarding Pregnancy, Contraception, and Related Issues ... all unmarried young adults ages 18-29 believe pregnancy is ... 86% of women) and say that it is important ... of men and 88% of women), according to new ... and Unplanned Pregnancy. Even so: ,, Only ...
(Date:12/14/2009)... The combination of AQUALIPO™ and NaturalFill™ revolutionary new liposuction and ... wrinkling, and plump lips all in one minimally invasive treatment. ... ... -- The combination of AQUALIPO™ and NaturalFill™ can remove excess ... and lips to help people slim down, reduce facial wrinkling ...
(Date:12/14/2009)... Americold Realty Trust ("Americold") announced today that ... with the U.S. Securities and Exchange Commission (the "SEC") ... common shares. The number of shares to be offered ... yet been determined. The common shares to be sold ... Americold. ,, The joint book-running managers of the ...
(Date:12/14/2009)... COLUMBUS, Ga., Dec. 14 Aflac Incorporated ... (par value) of thirty-year senior notes with a ... at a price of 98.951 to yield 6.984%. ... issuance for debt repayment and general corporate purposes. ... issue, Aflac Incorporated President and Chief Financial Officer ...
(Date:12/14/2009)... Calif., Dec. 14 Tough Enough To Wear ... breast cancer, celebrated its fifth anniversary at the ... the Wrangler National Finals Rodeo (Wrangler NFR) in ... with rough-and-tumble rodeo cowboys, the support of the ... the sold-out crowd sported pink shirts, hats, bracelets ...
Breaking Medicine News(10 mins):Health News:Although Most Unmarried Young Adults Want to Avoid Pregnancy, Many Don't Use Contraception, Know Little About It, and Think It Doesn't Make Much Difference 2Health News:Although Most Unmarried Young Adults Want to Avoid Pregnancy, Many Don't Use Contraception, Know Little About It, and Think It Doesn't Make Much Difference 3Health News: Free Webinar Series at Aqualipo.com Shows How New Combination Liposuction/Fat Transfer Treatment Helps Patients Slim Down and Reduce Facial Wrinkling 2Health News: Free Webinar Series at Aqualipo.com Shows How New Combination Liposuction/Fat Transfer Treatment Helps Patients Slim Down and Reduce Facial Wrinkling 3Health News:Americold Realty Trust Files Registration Statement for Proposed Initial Public Offering 2Health News:Aflac Incorporated Prices $400 Million of 30-Year Senior Notes 2Health News:Aflac Incorporated Prices $400 Million of 30-Year Senior Notes 3Health News:Aflac Incorporated Prices $400 Million of 30-Year Senior Notes 4Health News:Tough Enough To Wear Pink(TM) Celebrates Fifth Anniversary 2Health News:Tough Enough To Wear Pink(TM) Celebrates Fifth Anniversary 3Health News:Tough Enough To Wear Pink(TM) Celebrates Fifth Anniversary 4
... of Michigan’s researchers has revealed that those children who live in ... put on weight. As many as 16% of those belonging to ... reported to be overweight, while in the UK the number of ... 1990s. ,The researchers, led by Julie Lumeng, looked ...
... IT was! ,To help million of people worldwide who made ... and avoiding quick fixes to lose weight. ,The idea is ... ,"Atkins - thank goodness, they're bankrupt," Davis said. "We ... view as the weight loss may be evident at first but ...
... right to choose health policy to Briton citizen could increase ... at // reducing the waiting time of the ... make their own choice of treatment at any of the ... and choice. Health Secretary as assured that strict monitoring would ...
... tackle increasingly difficult acrobatic stunts and are paying the price ... study says. ,Cheerleaders catapult in the air, ... fall to the ground. They also make it to the ... the journal Pediatrics estimates that 208,800 young people aged 5 ...
... in the process of bone loss based on a ... // approaches to the treatment of osteoporosis. ... Bonn, working in collaboration with scientists from Israel, the ... particular gene defect have a lower bone density. This ...
... exception. To all those who wish kick the habit and ... Smokers // world over are swearing by Laser ... likened to a modern form of acupuncture has recorded higher ... most other smoking cessation programmes. For the first time, residents ...
Other Medicine News:Health News:Surroundings Have An Effect On Weight 2Health News:Nutritionists give helpful advice to loose weight and say hello to 2006 with a smile 2Health News:Cheerleaders run high risk of injury-US study 2Health News:Zap the butt (cigarette) with Laser Therapy 2
... water-cooled secondary condenser to trap residual solvent ... a powerful PTFE membrane vacuum pump designed ... Ideally suited for use with ... Laboratory vacuum source for instruments including vacuum ...
... water-cooled secondary condenser to trap residual solvent ... membrane vacuum pump designed to handle most ... suited for use with up to two ... for instruments including vacuum ovens, concentrators, gel ...
... is a multi-tasking vacuum source and solvent ... vapor trap and a maintenance-free, oil-free vacuum ... easy-to-use, wide-mouth glass condensation flask collects all ... easy disposal. The UVS400A provides an ideal ...
Universal vacuum pump (capacity 34 L/min, 8 mbar vacuum abs.)...
Medicine Products: